Emily Rinderknecht
Papers
2
Total Citations
22
H-Index
2
About
Emily Rinderknecht is a rising leader in urologic oncology and reconstructive surgery, known for advancing minimally invasive techniques that improve patient outcomes. Her primary research focuses on complex ureteral reconstruction and robotic partial nephrectomy, where she has made significant contributions to optimizing surgical approaches. In her landmark two-center comparison on ureteroplasty with buccal mucosa onlay grafts, Rinderknecht demonstrated that both open and robotic approaches yield high success rates for managing challenging proximal ureteral strictures, while the robotic technique notably reduces intraoperative blood loss—a finding that has already garnered 13 citations since 2024. She is also the lead investigator of the ROPARN study, a randomized controlled feasibility trial comparing retroperitoneal versus transperitoneal robot-assisted partial nephrectomy. This work, cited 9 times in 2025, aims to confirm that the retroperitoneal approach offers equivalent oncological efficacy with potential time savings and lower peri-operative morbidity. Rinderknecht’s research is shaping the future of urologic surgery by providing evidence-based guidance on technique selection, directly impacting surgical planning and recovery for patients with kidney tumors and ureteral strictures.
Research Focus
Key Achievements
Top Papers
- 1
- 2